Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Everything You Need To Know About Mononucleosis PDF full book. Access full book title Everything You Need To Know About Mononucleosis.
| Author | : Paul Smart |
| Publisher | : The Rosen Publishing Group, Inc |
| Total Pages | : 72 |
| Release | : 1999-12-15 |
| Genre | : Juvenile Nonfiction |
| ISBN | : 9780823925506 |
Looks at the factors that cause some teenagers to practice self-mutilation, and how they can be helped.
| Author | : B Daniels |
| Publisher | : Independently Published |
| Total Pages | : 0 |
| Release | : 2024-01-28 |
| Genre | : Health & Fitness |
| ISBN | : |
A viral disease called mono, also known as infectious mononucleosis, is frequently brought on by the Epstein-Barr virus (EBV). Because of its link to viral transmission by saliva, it's commonly referred to as the "kissing disease". Despite its prevalence in youth and young adults, mono can afflict individuals of any age. Important Points: Agent of Causation: The Epstein-Barr virus (EBV), which belongs to the herpesvirus family, is the main cause of mono. The cytomegalovirus (CMV) and other viruses can also produce symptoms resembling these. Transfer: Because the virus is usually spread by salivary contact, kissing is associated with it. Other respiratory secretions are another way that it might spread. Typical Symptoms: Severe weariness, sore throat, enlarged lymph nodes, and fever are typical signs of mono. In addition, headaches, aches in the muscles, and an enlarged spleen are possible symptoms of mono. Time of Incubation: Mono typically takes four to six weeks to incubate, during which time an infected individual may not show any symptoms but is still able to spread the virus to other people. A physical examination, laboratory testing, and symptoms are frequently used to make a diagnosis. Certain antibodies and a higher concentration of white blood cells may be detected by blood testing.
| Author | : Gaby Alez |
| Publisher | : |
| Total Pages | : 151 |
| Release | : 2012 |
| Genre | : Mononucleosis |
| ISBN | : |
| Author | : M. A. Epstein |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 467 |
| Release | : 2012-12-06 |
| Genre | : Medical |
| ISBN | : 3642672361 |
The Epstein-Barr virus was discovered 15 years ago. Since that time an immense body of information has been accumu lated on this agent which has come to assume great signifi cance in many different fields of biological science. Thus, the virus has very special relevance in human medicine and oncology, in tumor virology, in immunology, and in mole cular virology, since it is the cause of infectious mononu cleosis and also the first human cancer virus, etiologically related to endemic Burkitt's lymphoma and probably to nasopharyngeal carcinoma. In addition, continuous human lymphoid cell lines initiated and maintained by the transform ing function of the virus genome provide a laboratory tool with wide and ever-growing applications. Innumerable papers on the Epstein-Barr virus have ap peared over recent years and reports of work with this agent now constitute a veritable flood. The present book provides the first and only comprehensive, authoritative over-view of all aspects of the virus by authors who have been the original and major contributors in their particular disciplines. A complete and up-to-date survey of this unique and important agent is thus provided which should be of great interest to experts, teachers, and students engaged in cancer research, virology, immunology, molecular biology, epide miology, and cell culture. Where topics have been dealt with from more than one of these viewpoints, some inevitable overlap and duplication has resulted; although this has been kept to a minimum, it has been retained in some places because of positive usefulness.
| Author | : |
| Publisher | : |
| Total Pages | : |
| Release | : |
| Genre | : |
| ISBN | : |
Features an article "What Every Pediatrician Should Know About Infectious Mononucleosis," written by Myrna R. Nieves and published in the December 1997 "Pediatric Bulletin." Discusses clinical manifestations, complications, diagnosis, and treatment.
| Author | : Ann Arvin |
| Publisher | : Cambridge University Press |
| Total Pages | : 1325 |
| Release | : 2007-08-16 |
| Genre | : Medical |
| ISBN | : 1139461648 |
This comprehensive account of the human herpesviruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein–Barr virus, Kaposi's Sarcoma-associated herpesvirus, cytomegalovirus, HHV6A, 6B and 7, and varicella-zoster virus. The viral diseases and cancers they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology of infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth, both scientifically and in terms of clinical guidelines for patient care. The text is illustrated generously throughout and is fully referenced to the latest research and developments.
| Author | : Christian Münz |
| Publisher | : Springer |
| Total Pages | : 0 |
| Release | : 2015-10-12 |
| Genre | : Medical |
| ISBN | : 9783319228211 |
Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.
| Author | : P. S. Gardner |
| Publisher | : Butterworth-Heinemann |
| Total Pages | : 336 |
| Release | : 2014-06-28 |
| Genre | : Medical |
| ISBN | : 1483192172 |
Rapid Virus Diagnosis: Application of Immunofluorescence presents developments in immunofluorescence as a technique for the diagnosis of virus infections. It discusses the effective and rapid methods for the diagnosis of virus infections. It addresses the application of fluorescent antibody techniques to the diagnosis and the investigation of virus infections and the assessment of their value both to the clinician and to the virologist. Some of the topics covered in the book are the fluorescence microscopy; nature of fluorescence; filter systems; transmitted light microscopy; interference filters for transmitted light microscopy; lamp centration and alignment of microscope; contrast-fluorescence condensers; photomicrography; and choice of microscope. The culture of viruses for production of antiserum is fully covered. The selection of cell lines or tissues for virus culture is discussed in detail. The text describes in depth the fluorescent antibody staining techniques. The preparation of specimens from respiratory infections is presented completely. A chapter is devoted to the respiratory syncytial virus. Another section focuses on the analysis influenza virus, paramyxoviruses, and picornaviruses. The book can provide useful information to doctors, virologists, students, and researchers.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 472 |
| Release | : 2001-02-21 |
| Genre | : Medical |
| ISBN | : 0309174988 |
Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis. What is next? There are many pathogens, autoimmune diseases, and cancers that may be promising targets for vaccine research and development. This volume provides an analytic framework and quantitative model for evaluating disease conditions that can be applied by those setting priorities for vaccine development over the coming decades. The committee describes an approach for comparing potential new vaccines based on their impact on morbidity and mortality and on the costs of both health care and vaccine development. The book examines: Lessons to be learned from the polio experience. Scientific advances that set the stage for new vaccines. Factors that affect how vaccines are used in the population. Value judgments and ethical questions raised by comparison of health needs and benefits. The committee provides a way to compare different forms of illness and set vaccine priorities without assigning a monetary value to lives. Their recommendations will be important to anyone involved in science policy and public health planning: policymakers, regulators, health care providers, vaccine manufacturers, and researchers.
| Author | : Christian Münz |
| Publisher | : Springer |
| Total Pages | : 493 |
| Release | : 2015-10-01 |
| Genre | : Medical |
| ISBN | : 331922834X |
Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.
